Bojana Jovanović

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

Brian D. Lehmann, Bojana Jovanović, Xi Chen et al. · PLoS ONE · 2016 · 1.4K citations · Full text

Medicine, Cancer Biology, Oncology +17

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer

Shaokun Shu, Hua‐Jun Wu, Jennifer Y. Ge et al. · Molecular Cell · 2020 · 207 citations · Full text

Medicine, Oncology, Pharmacology +17

A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67

Bojana Jovanović, Ingrid A. Mayer, Erica L. Mayer et al. · Clinical Cancer Research · 2017 · 147 citations · Full text

Medicine, Oncology, Pharmacology +17

Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition

Anne Fassl, Christopher T. Brain, Monther Abu-Remaileh et al. · Science Advances · 2020 · 105 citations · Full text

Medicine, Cancer Biology, Oncology +15

A versatile valve-enabled microfluidic cell co-culture platform and demonstration of its applications to neurobiology and cancer biology

Yandong Gao, Devi Majumdar, Bojana Jovanović et al. · Biomedical Microdevices · 2011 · 101 citations

Engineering, Cancer Biology, Neurobiology +12